B
Bernard Bannwarth
Researcher at University of Bordeaux
Publications - 160
Citations - 5373
Bernard Bannwarth is an academic researcher from University of Bordeaux. The author has contributed to research in topics: Arthritis & Rheumatoid arthritis. The author has an hindex of 31, co-authored 160 publications receiving 5041 citations.
Papers
More filters
Journal ArticleDOI
EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)
K M Jordan,Nigel K Arden,M Doherty,Bernard Bannwarth,Johannes W. J. Bijlsma,Paul Dieppe,K. P. Günther,H J Hauselmann,Gabriel Herrero-Beaumont,P Kaklamanis,Stefan Lohmander,Burkhard F. Leeb,Michel Lequesne,Bernard Mazières,E. Martin-Mola,Karel Pavelka,Adrian Pendleton,Leonardo Punzi,U Serni,B Swoboda,G. Verbruggen,I Zimmerman-Gorska,Maxime Dougados +22 more
TL;DR: The updated EULAR recommendations support some of the previous propositions published in 2000 but also include modified statements and new propositions.
Journal ArticleDOI
Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer—clinical aspects and relationship with tumour response: a single-centre prospective cohort study
Marie Kostine,Léa Rouxel,Thomas Barnetche,R. Veillon,Florent Martin,Caroline Dutriaux,Léa Dousset,Anne Pham-Ledard,Sorilla Prey,Marie Beylot-Barry,Amaury Daste,Marine Gross-Goupil,Julie Lallier,Alain Ravaud,Edouard Forcade,Bernard Bannwarth,Marie-Elise Truchetet,Christophe Richez,Nadia Mehsen,Thierry Schaeverbeke +19 more
TL;DR: Tumour response was significantly higher in patients who experienced rheumatic irAEs and their management is of major interest, since ICIs are used with increasing frequency.
Journal ArticleDOI
Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis
TL;DR: The pharmacokinetics of low-dose methotrexate appears to be highly variable and largely unpredictable even in patients with normal renal and hepatic function, so the dosage must be individualised because of interindividual variability in the dose-response curve.
Journal ArticleDOI
Methotrexate in rheumatoid arthritis. An update.
TL;DR: Two meta-analyses showed that methotrexate is among the most efficacious of slow-acting antirheumatic agents, together with parenteral gold (sodium aurothiomalate), penicillamine and sulfasalazine, and has one of the best efficacy/toxicity ratios.
Journal ArticleDOI
Fibromyalgia syndrome in the general population of France: a prevalence study.
Bernard Bannwarth,Francis Blotman,Katell Roué-Le Lay,Jean-Paul Caubère,Etienne André,Charles Taieb +5 more
TL;DR: The findings suggest that FM is also a major cause of widespread pain in France since a point prevalence of 1.4% would translate in approximately 680,000 patients.